HealthLynked Corp. (OTCQB: HLYK), a healthcare technology company focused on AI-powered patient engagement, care coordination, and provider connectivity, has selected DRCARE247 as its telemedicine partner. The partnership will integrate virtual care into the HealthLynked mobile application and website, enabling users to transition seamlessly from AI-powered health guidance to provider discovery, appointment scheduling, virtual consultations, and medical record management within a single platform.
According to the company, the integrated telemedicine platform is expected to begin launching in selected geographic regions over the next three months, followed by expansion into additional U.S. markets, subject to provider availability and applicable state requirements. The integration is designed to work alongside HealthLynked’s AI-powered patient assistant and, where clinically appropriate and permitted, may include prescription management as part of virtual consultations.
This move signals a significant step in the ongoing convergence of artificial intelligence, telehealth, and electronic health records. By consolidating these functions, HealthLynked aims to reduce fragmentation in the patient experience—a persistent challenge in digital health. For patients, the integration could mean faster access to care, fewer platforms to navigate, and better continuity between AI-driven symptom checkers and actual clinical encounters. For providers, it offers a more streamlined workflow and potential cost savings through improved care coordination.
The partnership also positions HealthLynked to compete more effectively in the rapidly growing telemedicine market, which has seen sustained demand since the COVID-19 pandemic. The company’s cloud-based platform connects patients with providers for virtual or in-office appointments and consolidates medical records into one secure, accessible location. With AI-driven insights, integrated telehealth services, and intelligent patient engagement tools, HealthLynked empowers patients and providers to coordinate care more effectively while delivering savings on prescriptions and healthcare services.
Investors and industry observers may view the DRCARE247 deal as a validation of HealthLynked’s strategy to become a one-stop shop for digital care. The company’s enterprise partnerships offer scalable solutions to healthcare networks, employers, insurers, accountable care organizations, and digital health innovators. As the platform rolls out, its success will depend on execution, regulatory compliance across states, and adoption by both patients and providers.
For those tracking the latest developments in biotechnology, biomedical sciences, and life sciences, BioMedWire provides ongoing coverage. The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYLK. To view the full press release, visit https://ibn.fm/HVq1Y.
BioMedWire is one of 75+ brands within the Dynamic Brand Portfolio at IBN, delivering access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, and social media distribution. For more information, visit https://www.BioMedWire.com. Please see full terms of use and disclaimers on the BioMedWire website: https://www.BioMedWire.com/Disclaimer.
